Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Assets (2016 - 2025)

Historic Assets for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $493.5 million.

  • Orthopediatrics' Assets rose 85.67% to $493.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $493.5 million, marking a year-over-year increase of 85.67%. This contributed to the annual value of $473.2 million for FY2024, which is 785.51% up from last year.
  • As of Q3 2025, Orthopediatrics' Assets stood at $493.5 million, which was up 85.67% from $503.6 million recorded in Q2 2025.
  • Orthopediatrics' 5-year Assets high stood at $503.6 million for Q2 2025, and its period low was $301.0 million during Q1 2022.
  • In the last 5 years, Orthopediatrics' Assets had a median value of $430.8 million in 2024 and averaged $407.8 million.
  • Over the last 5 years, Orthopediatrics' Assets had its largest YoY gain of 7988.16% in 2021, and its largest YoY loss of 634.29% in 2021.
  • Quarter analysis of 5 years shows Orthopediatrics' Assets stood at $304.3 million in 2021, then surged by 40.57% to $427.7 million in 2022, then rose by 2.58% to $438.7 million in 2023, then grew by 7.86% to $473.2 million in 2024, then grew by 4.28% to $493.5 million in 2025.
  • Its Assets was $493.5 million in Q3 2025, compared to $503.6 million in Q2 2025 and $470.2 million in Q1 2025.